Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2004 2
2005 4
2006 1
2007 1
2008 6
2009 2
2010 2
2011 4
2012 5
2013 3
2014 6
2015 3
2016 7
2017 1
2018 5
2019 4
2020 3
2021 5
2022 6
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Results by year

Filters applied: . Clear all
Page 1
Type I IFN signature in primary Sjögren's syndrome patients.
Brkic Z, Versnel MA. Brkic Z, et al. Among authors: versnel ma. Expert Rev Clin Immunol. 2014 Apr;10(4):457-67. doi: 10.1586/1744666X.2014.876364. Epub 2014 Jan 22. Expert Rev Clin Immunol. 2014. PMID: 24450331 Review.
Hyperresponsive cytosolic DNA-sensing pathway in monocytes from primary Sjögren's syndrome.
Huijser E, Bodewes ILA, Lourens MS, van Helden-Meeuwsen CG, van den Bosch TPP, Grashof DGB, van de Werken HJG, Lopes AP, van Roon JAG, van Daele PLA, Brkic Z, Dik WA, Versnel MA. Huijser E, et al. Among authors: versnel ma. Rheumatology (Oxford). 2022 Aug 3;61(8):3491-3496. doi: 10.1093/rheumatology/keac016. Rheumatology (Oxford). 2022. PMID: 35022662 Free PMC article.
Immune and neuroimmune alterations in mood disorders and schizophrenia.
Drexhage RC, Weigelt K, van Beveren N, Cohen D, Versnel MA, Nolen WA, Drexhage HA. Drexhage RC, et al. Among authors: versnel ma. Int Rev Neurobiol. 2011;101:169-201. doi: 10.1016/B978-0-12-387718-5.00007-9. Int Rev Neurobiol. 2011. PMID: 22050852 Review.
2022 EULAR points to consider for the measurement, reporting and application of IFN-I pathway activation assays in clinical research and practice.
Rodríguez-Carrio J, Burska A, Conaghan PG, Dik WA, Biesen R, Eloranta ML, Cavalli G, Visser M, Boumpas DT, Bertsias G, Wahren-Herlenius M, Rehwinkel J, Frémond ML, Crow MK, Rönnblom L, Versnel MA, Vital EM. Rodríguez-Carrio J, et al. Among authors: versnel ma. Ann Rheum Dis. 2023 Jun;82(6):754-762. doi: 10.1136/ard-2022-223628. Epub 2023 Mar 1. Ann Rheum Dis. 2023. PMID: 36858821
Leflunomide/hydroxychloroquine combination therapy targets type I IFN-associated proteins in patients with Sjögren's syndrome that show potential to predict and monitor clinical response.
Hamkour S, van der Heijden EH, Lopes AP, Blokland SLM, Bekker CPJ, Van Helden-Meeuwsen CG, Versnel MA, Kruize AA, Radstake TR, Leavis HL, Hillen MR, van Roon JA. Hamkour S, et al. Among authors: versnel ma. RMD Open. 2023 Aug;9(3):e002979. doi: 10.1136/rmdopen-2023-002979. RMD Open. 2023. PMID: 37532471 Free PMC article.
70 results